Rejection, Transplant Completed Phase 2 Trials for Bortezomib (DB00188)
Also known as: Graft Rejection / Transplant rejections / Transplant Rejection / Transplanted organ rejection (disorder) / Graft rejection (finding) / Complication of transplanted organ (disorder)
Indication | Status | Phase |
---|---|---|
DBCOND0030946 (Rejection, Transplant) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00771875 | Randomized Trial for Mixed Acute Rejection | Treatment |